Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03544515Not ApplicableCompleted

Peri-implantitis Treatment: Clinical Results of Conventional Treatment vs. the Addition of Biolase

Role: collaborator

NCT05276817Phase 1Completed

Perio. Maint. With Diode LBR

Role: lead

NCT04169139Not ApplicableCompleted

Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Periodontitis

Role: collaborator

NCT04027686Not ApplicableCompleted

Clinical Evaluation of Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Gum Disease

Role: collaborator

NCT04120948Not ApplicableCompleted

Laser Tongue Debridement for Oral Malodor

Role: collaborator

All 5 trials loaded